O'Rourke & Company’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History
Bought
Maintained
Sold
Other funds holding HEAL
KAS
UCIG
RJA
O'Rourke & Company's HEAL Position: Q2 2022 in Review
O'Rourke & Company sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q2 2022, closing a stake of 5,247 shares — an estimated $228K sold.
O'Rourke & Company first reported a position in HEAL in Q4 2021 and held it in 2 quarters. The position peaked at $268K in Q4 2021. 55 funds tracked by Wall St. Rank hold HEAL as of Q2 2022.
- O'Rourke & Company reported no remaining Global X Funds Global X HealthTech ETF position as of Q2 2022 after selling out during the quarter.
- O'Rourke & Company sold 5,247 Global X Funds Global X HealthTech ETF shares in Q2 2022, an estimated $228K.
- O'Rourke & Company first reported a position in Global X Funds Global X HealthTech ETF in Q4 2021 and held it in 2 quarters.
- O'Rourke & Company's Global X Funds Global X HealthTech ETF position peaked at $268K in Q4 2021.
- 55 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q2 2022.
Based on O'Rourke & Company's 13F filing for Q2 2022, filed 12 Aug 2022.